MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 1..10 of 24 - per page Next page
Order by
One of Pharmalicensing's recent clients is Gary Clark of Immunology Laboratories, based in Alabama in the United States. More
In 2005, when there have been no outbreaks of poliomyelitis in the Western hemisphere for over a decade, it is difficult to appreciate the stark terror that accompanied epidemics in the 1950s. More
It is difficult to imagine that the Golden Retriever puppy in this toe-curlingly cute photograph could soon harbour a parasite capable of causing significant morbidity, even death, to its adoring owner. More
It wasn't so long ago that nearly all big pharma outfits and even many biotech firms put vaccine development on the very bottom of their wish list. More
If you had contracted tuberculosis (TB) in the first half of the last century, the most advanced treatment available was rest in a sanatorium and collapsing the lung; not surprisingly, the chances of survival were only around 50%. More
Has one of your male neighbours recently started driving recklessly, gambling wildly or become something of a delinquent? If so, one possible explanation is chronic infection with the parasitic protozoon Toxoplasma gondii. More
For fifty years scientists have been trying - and failing - to develop a vaccine against malaria, but last October the Lancet published details of the most effective candidate yet, which could be licensed in 2010. More
A recent report from the Pharmaceutical Research and Manufacturers of America (PhRMA; Washington, DC) lists drugs and vaccines in clinical development for HIV/AIDS and related conditions and also details related epidemiologic and cost facts. More
The incidence of invasive fungal infections has risen dramatically in the last twenty years. This paper looks at the current situation regarding fungal infections and antifungal drugs, and discusses future trends and needs. More
Today the UK plays host to more than 60 million rats, this population explosion is important as feral rats are the main animal reservoir for Leptospira interrogans, the causative organism of Leptospirosis. More
Displaying 1..10 of 24 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us